NCT03857061

Brief Summary

Our overall research goal for this project is to create a wearable device and mobile application, appealing to patients with Chronic Obstructive Pulmonary Disease (COPD), which provides them with appropriate self-management tools and detects AECOPDs early to permit prompt treatment and prevent severe exacerbations requiring hospitalization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2018

Completed
7 months until next milestone

First Posted

Study publicly available on registry

February 27, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

June 29, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

January 24, 2025

Status Verified

January 1, 2025

Enrollment Period

1.9 years

First QC Date

July 23, 2018

Last Update Submit

January 22, 2025

Conditions

Keywords

wearablesself-monitoring

Outcome Measures

Primary Outcomes (1)

  • Change in self-management as measured by the Mastery sub-section of the Chronic Respiratory Disease Questionnaire

    Can an app designed for patients with COPD that includes biosensor feedback improve self-management of COPD? We will use the Mastery sub-section of the Chronic Respiratory Disease Questionnaire to measure our research question. Mastery is measured with a 7-point likert scale where higher scores indicate better health-related mastery.

    6 months

Secondary Outcomes (4)

  • Change in self-efficacy as measured by the COPD Self-Efficacy Scale

    6 months

  • Change in Health related quality of life as measured by the St. George's respiratory questionnaire

    6 months

  • Change in symptom scale as measured by the MRC dyspnea scale

    6 months

  • Accuracy of our derived prediction algorithm to detect acute exacerbations as measured by the daily symptom score.

    6 months

Study Arms (1)

COPD Patients

This is a prospective cohort study enrolling patients with COPD to 1) wear a smartwatch that passively senses heart rate, motion, audio, 2) use a smartphone that can obtain oxygen saturation upon demand, 3) use a self-management app on the smartwatch, smartphone and a webapp.

Device: smartphone, smartwatch, WearCOPDv2 application

Interventions

WearCOPD2 consists of hardware and software components. 6.1 Hardware The hardware for wearCOPDv2 consists of three main components; (1) a smartwatch, (2) a phone, and (3) a server. 6.2 Software The wearCOPDv2 system has two main software components: 1. Data collection service 2. Participant user interface

COPD Patients

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The investigators will recruit patients who have clinically relevant COPD who live at home. They will be identified in clinics and the wards by members of their care team. Posters informing people of the study will also be posted at University Health Network (UHN) with a contact number.

You may qualify if:

  • Able to speak English
  • Moderate to very severe COPD (GOLD C and D) as defined by the GOLD guidelines
  • Clinically relevant disease, as defined by a history of exacerbation in the previous 12 months
  • Previous spirometry or Pulmonary Function Test results of Forced Expiration Volume/Forced Vital Capacity (FEV1/FVC) \<0.70 with an FEV1 below 80% predicted
  • Patient resides at home (not long term care residence or another hospital)

You may not qualify if:

  • Pulmonary condition other than COPD as the main respiratory disease such as bronchiectasis or asthma
  • Rapid lethal disease, e.g. lung cancer, advance heart failure, end-stage renal disease
  • Any medical conditions that would impair their ability to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Toronto General Hospital

Toronto, Ontario, M5G 2C4, Canada

Location

Related Publications (1)

  • Wu R, de Lara E, Liaqat D, Liaqat S, Chen JL, Son T, Gershon AS. Feasibility of a wearable self-management application for patients with COPD at home: a pilot study. BMC Med Inform Decis Mak. 2024 Mar 5;24(1):66. doi: 10.1186/s12911-024-02461-y.

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Robert Wu

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
General Internal Medicine Site Director

Study Record Dates

First Submitted

July 23, 2018

First Posted

February 27, 2019

Study Start

June 29, 2019

Primary Completion

June 1, 2021

Study Completion

December 30, 2023

Last Updated

January 24, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

UHN, research personnel will have direct access to the source documents with identifying information. UHN, University of Toronto (UofT) and Samsung Research America (SRA) will have access to the anonymized subject data for analysis purposes.

Shared Documents
STUDY PROTOCOL
Time Frame
Data will become available right away for up to 5 years.
Access Criteria
Data will be stored and analyzed on the secure UHN server

Locations